Bococizumab is a remarkable anti-PCSK9 antibody effectively developed to combat hypercholesterolemia. This therapeutic agent works by the PCSK9 protein, a essential regulator of cholesterol concentrations. By https://bookmark-template.com/story28242665/bococizumab-a-novel-anti-pcsk9-antibody-for-hypercholesterolemia